1. Signaling Pathways
  2. Immunology/Inflammation
  3. Toll-like Receptor (TLR)

Toll-like Receptor (TLR)

Toll-like receptors (TLRs) are a class of proteins that play a key role in the innate immune system. They are single, membrane-spanning, non-catalytic receptors usually expressed in sentinel cells such as macrophages and dendritic cells, that recognize structurally conserved molecules derived from microbes. Once these microbes have breached physical barriers such as the skin or intestinal tract mucosa, they are recognized by TLRs, which activate immune cell responses. The TLRs include TLR1, TLR2, TLR3, TLR4, TLR5, TLR6, TLR7, TLR8, TLR9, TLR10, TLR11, TLR12, and TLR13. Toll-Like Receptors (TLRs) play a critical role in the early innate immune response to invading pathogens by sensing microorganism and are involved in sensing endogenous danger signals. TLRs are evolutionarily conserved receptors are homologues of the Drosophila Toll protein, discovered to be important for defense against microbial infection. TLRs recognize highly conserved structural motifs known as pathogen-associated microbial patterns (PAMPs), which are exclusively expressed by microbial pathogens.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-159747
    Aluminum hydroxide adjuvant aluminum : 4~6 mg/mL
    Activator
    Aluminum hydroxide adjuvant (aluminum : 4~6 mg/mL) is a micron level water-based aluminum hydroxide adjuvant. The aluminum content is 4 - 6 mg/ml. It has a strong adsorption capacity for negatively charged antigens, a significant sustained-release effect, no stress response, high safety, and can effectively induce immune responses in the body. It is suitable for various veterinary vaccines, including inactivated vaccines or gene-engineered subunit vaccines for bacterial and viral diseases of livestock and poultry.
    Aluminum hydroxide adjuvant aluminum : 4~6 mg/mL
  • HY-RS14592
    Tlr6 Rat Pre-designed siRNA Set A
    Inhibitor

    Tlr6 Rat Pre-designed siRNA Set A contains three designed siRNAs for Tlr6 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Tlr6 Rat Pre-designed siRNA Set A
  • HY-RS14590
    TLR6 Human Pre-designed siRNA Set A
    Inhibitor

    TLR6 Human Pre-designed siRNA Set A contains three designed siRNAs for TLR6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    TLR6 Human Pre-designed siRNA Set A
  • HY-N12670
    Egg oil
    Inhibitor 99.0%
    Egg oil is a natural oil, which consists primarily of cholesterol, lecithin and glycerides of the fatty acids. Egg oil exhibits activity in regulating the gut microbial dysbiosis, alleviating obesity, insulin resistance and inflammation.
    Egg oil
  • HY-141569
    Ganglioside GD1a
    Inhibitor 99%
    Ganglioside GD1a modulates toxic and inflammatory effects of E. coli lipopolysaccharide by preventing TLR4 translocation into lipid rafts. Ganglioside GD1a significantly reduces the effect of LPS on the decrease of cell survival and on stimulation of reactive oxygen species production.
    Ganglioside GD1a
  • HY-153838A
    ODN 5328 sodium
    Inhibitor
    ODN 5328 (ODN 2395 Control) sodium can be used as a sequence control for C-class ODN 2395. ODN 5328 sodium shares the sequence with ODN 2395 but contain GpC dinucleotides instead of the CpG motifs.
    ODN 5328 sodium
  • HY-139785
    Cavrotolimod
    Inhibitor
    Cavrotolimod is an immunostimulatory spherical nucleic acid (SNA) modified with type B CpG oligonucleotides designed to agonize TLR9 and elicit immune responses useful in oncology applications.
    Cavrotolimod
  • HY-B1370A
    (S)-Hydroxychloroquine
    Inhibitor
    (S)-Hydroxychloroquine ((S)-HCQ) is the enantiomer of Hydroxychloroquine. Hydroxychloroquine, a synthetic antimalarial agent, inhibits Toll-like receptor 7/9 (TLR7/9) signaling, and shows efficiently inhibits SARS-CoV-2 infection in vitro.
    (S)-Hydroxychloroquine
  • HY-145618
    Polvitolimod
    Agonist
    Polvitolimod is a TLR7 agonist for research of cancer and infectious disease.
    Polvitolimod
  • HY-139575
    Guretolimod
    Agonist
    Guretolimod (DSP-0509) is a Toll-like receptor 7 (TLR7) agonist.
    Guretolimod
  • HY-B1370B
    (R)-Hydroxychloroquine
    Inhibitor
    (R)-Hydroxychloroquine is the enantiomer of Hydroxychloroquine. Hydroxychloroquine is a synthetic antimalarial agent which can also inhibit Toll-like receptor 7/9 (TLR7/9) signaling. Hydroxychloroquine is efficiently inhibits SARS-CoV-2 infection in vitro.
    (R)-Hydroxychloroquine
  • HY-139017A
    TLR7/8 agonist 4 TFA
    Agonist
    TLR7/8 agonist 4 TFA (compound 41) is a potent TLR7/8 agonist. TLR7/8 agonist 4 TFA has anti-cancer activity.
    TLR7/8 agonist 4 TFA
  • HY-177568
    Mozistobart zoratolimod
    Agonist
    Mozistobart zoratolimod is an antibody-oligonucleotide conjugate (AOC) composed of a humanized monoclonal antibody (HY-P990930 Mozistobart) targe ting CD22 linked to a TLR9 agonist. It is used for the study of cancer immunotherapy.
    Mozistobart zoratolimod
  • HY-148980
    Polyinosinic acid
    Polyinosinic acid is a single stranded homonucleic acid, which is a Toll-like Receptor 3 (TLR3) ligand. Polyinosinic acid enhances cellular immune response through TLR3 and TRIF. Polyinosinic acid has potential applications in immune regulation.
    Polyinosinic acid
  • HY-141454A
    TLR8 agonist 2 hydrochloride
    Agonist
    TLR8 agonist 2 hydrochloride is a potent and selective TLR8 agonist with an EC50 of 3 nM for human TLR8. TLR8 agonist 2 hydrochloride shows less active against human TLR7 (EC50 of 33.33 μM).
    TLR8 agonist 2 hydrochloride
  • HY-141454
    TLR8 agonist 2
    Agonist
    TLR8 agonist 2 is a potent and selective TLR8 agonist with an EC50 of 3 nM for human TLR8. TLR8 agonist 2 shows less active against human TLR7 (EC50 of 33.33 μM).
    TLR8 agonist 2
  • HY-147236
    TLR7/8 agonist 7
    Agonist
    TLR7/8 agonist 7 (compound 10) is a TLR7/8 agonist. TLR7/8 agonist 7 activates a variety of immune cells and it can be used to synthesize immune stimulating antibody conjugate (ISAC) molecules. TLR7/8 agonist 7 can be used for the research of immunity.
    TLR7/8 agonist 7
  • HY-160040A
    Cobitolimod sodium
    Agonist
    Cobitolimod sodium is a DNA oligonucleotide agonist of TLR-9 with anti-inflammatory activity. Cobitolimod sodium inhibits Th17 cells and induces anti-inflammatory FoxP3 and IL-10 expression, inhibiting the IL-17 signaling pathway.
    Cobitolimod sodium
  • HY-147215
    UC-1V150
    Agonist
    UC-1V150 is a specific TLR7 (Toll-like receptor) agonist that stimulates cellular immune responses and has anti-tumor activity. UC-1V150 can be used to synthesize ISAC (Immune-Stimulating Antibody Conjugates) molecule.
    UC-1V150
  • HY-135811S
    Desethyl chloroquine-d4
    Inhibitor
    Desethyl chloroquine-d4 is the deuterium labeled Desethyl chloroquine. Desethyl chloroquine is a major desethyl metabolite of Chloroquine. Chloroquine diphosphate is an inhibitor of autophagy and toll-like receptors (TLRs). Desethyl chloroquine possesses antiplasmodic activity.
    Desethyl chloroquine-d<sub>4</sub>
Cat. No. Product Name / Synonyms Species Source
Cat. No. Product Name / Synonyms Application Reactivity

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.